...
首页> 外文期刊>Arteriosclerosis, thrombosis, and vascular biology >Transforming growth factor-β-activated kinase 1 regulates angiogenesis via AMP-activated protein kinase-α1 and redox balance in endothelial cells
【24h】

Transforming growth factor-β-activated kinase 1 regulates angiogenesis via AMP-activated protein kinase-α1 and redox balance in endothelial cells

机译:转化生长因子-β-活化的激酶1通过AMP-活化的蛋白激酶-α1调节血管生成和内皮细胞的氧化还原平衡

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE - : Transforming growth factor-β-activated kinase 1 (TAK1) is a mitogen-activated protein 3-kinase and an AMP-activated protein kinase (AMPK) kinase in some cell types. Although TAK1 mice display defects in developmental vasculogenesis, the role of TAK1 in endothelial cells has not been investigated in detail. APPROACH AND RESULTS - : TAK1 downregulation (small interfering RNA) in human endothelial cells attenuated proliferation without inducing apoptosis and diminished endothelial cell migration, as well as tube formation. Cytokine- and vascular endothelial growth factor (VEGF)-induced endothelial cell sprouting in a modified spheroid assay were abrogated by TAK1 downregulation. Moreover, VEGF-induced endothelial sprouting was impaired in aortic rings from mice lacking TAK1 in endothelial cells (TAK). TAK1 inhibition and downregulation also inhibited VEGF-stimulated phosphorylation of several kinases, including AMPK. Proteomic analyses revealed that superoxide dismutase 2 (SOD2) expression was reduced in TAK1-deficient endothelial cells, resulting in attenuated hydrogen peroxide production but increased mitochondrial superoxide production. Endothelial cell SOD2 expression was also attenuated by AMPK inhibition and in endothelial cells from AMPKα1 mice but was unaffected by inhibitors of c-Jun N-terminal kinase, p38, extracellular signal-regulated kinase 1/2, or phosphatidylinositol 3-kinase/Akt. Moreover, the impaired endothelial sprouting from TAK aortic rings was abrogated in the presence of polyethylene glycol-SOD, and tube formation was normalized by the overexpression of SOD2. A similar rescue of angiogenesis was observed in polyethylene glycol-SOD-treated aortic rings from mice with endothelial cell-specific deletion of the AMPKα1. CONCLUSIONS - : These results establish TAK1 as an AMPKα1 kinase that regulates vascular endothelial growth factor-induced and cytokine-induced angiogenesis by modulating SOD2 expression and the superoxide anion:hydrogen peroxide balance.
机译:目的-:在某些细胞类型中,转化生长因子-β激活激酶1(TAK1)是一种促分裂原激活的蛋白3激酶和AMP激活蛋白激酶(AMPK)激酶。尽管TAK1小鼠在发育性血管生成中显示缺陷,但尚未详细研究TAK1在内皮细胞中的作用。方法和结果-:人内皮细胞中TAK1的下调(小干扰RNA)可减弱增殖,而不会引起细胞凋亡,减少内皮细胞迁移以及管的形成。 TAK1下调取消了细胞因子和血管内皮生长因子(VEGF)诱导的在修改的球体测定法中的内皮细胞发芽。此外,在内皮细胞(TAK)中缺乏TAK1的小鼠的主动脉环中,VEGF诱导的内皮发芽受到损害。 TAK1抑制和下调也抑制了VEGF刺激的几种激酶(包括AMPK)的磷酸化。蛋白质组学分析表明,在TAK1缺陷型内皮细胞中,超氧化物歧化酶2(SOD2)的表达降低,导致过氧化氢产生减弱,但线粒体超氧化物产生增加。内皮细胞SOD2的表达也受到AMPK抑制作用的减弱和来自AMPKα1小鼠的内皮细胞的表达,但不受c-Jun N末端激酶,p38,细胞外信号调节激酶1/2或磷脂酰肌醇3-激酶/ Akt抑制剂的影响。此外,在存在聚乙二醇-SOD的情况下,可以消除TAK主动脉环受损的内皮萌发,并通过SOD2的过表达使管形成正常化。在来自具有AMPKα1内皮细胞特异性缺失的小鼠的聚乙二醇-SOD处理的主动脉环中观察到类似的血管生成拯救。结论-:这些结果确定TAK1为AMPKα1激酶,可通过调节SOD2表达和超氧阴离子:过氧化氢平衡来调节血管内皮生长因子诱导的和细胞因子诱导的血管生成。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号